Loading...
Journey Medical Corporation
DERM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.59
$-0.08(-1.04%)
Journey Medical Corporation (DERM) Financial Performance & Income Statement Overview
Review Journey Medical Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-29.11%
↓ 29.11%
Operating Income Growth
-559.77%
↓ 559.77%
Net Income Growth
-280.79%
↓ 280.79%
Operating Cash Flow Growth
-274.18%
↓ 274.18%
Operating Margin
-12.29%
↓ 12.29%
Gross Margin
66.48%
↑ 66.48%
Net Profit Margin
-14.76%
↓ 14.76%
ROE
-52.03%
↓ 52.03%
ROIC
-15.45%
↓ 15.45%
Journey Medical Corporation (DERM) Income Statement & Financial Overview
Review Journey Medical Corporation's (DERM) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $13.62M | $14.63M | $14.86M | $13.03M |
| Cost of Revenue | $2.24M | $5.29M | $6.54M | $6.82M |
| Gross Profit | $11.38M | $9.34M | $8.31M | $6.21M |
| Gross Profit Ratio | $0.84 | $0.64 | $0.56 | $0.48 |
| R&D Expenses | $218000.00 | $842000.00 | $913000.00 | $7.88M |
| SG&A Expenses | $10.06M | $11.40M | $10.33M | $8.42M |
| Operating Expenses | $9.15M | $12.24M | $11.24M | $16.30M |
| Total Costs & Expenses | $11.39M | $17.52M | $17.78M | $23.12M |
| Interest Income | $191000.00 | $188000.00 | $161000.00 | $217000.00 |
| Interest Expense | $831000.00 | $758000.00 | $563000.00 | $548000.00 |
| Depreciation & Amortization | $1.003M | $837000.00 | $839000.00 | $836000.00 |
| EBITDA | $3.42M | -$795000.00 | -$1.96M | -$9.06M |
| EBITDA Ratio | $0.25 | -$0.05 | -$0.13 | -$0.70 |
| Operating Income | $2.23M | -$2.89M | -$2.93M | -$10.09M |
| Operating Income Ratio | $0.16 | -$0.20 | -$0.20 | -$0.77 |
| Other Income/Expenses (Net) | -$652000.00 | $504000.00 | -$434000.00 | -$352000.00 |
| Income Before Tax | $1.58M | -$2.39M | -$3.36M | -$10.44M |
| Income Before Tax Ratio | $0.12 | -$0.16 | -$0.23 | -$0.80 |
| Income Tax Expense | $61000.00 | $0.00 | $0.00 | $792724.00 |
| Net Income | $1.52M | -$2.39M | -$3.36M | -$10.44M |
| Net Income Ratio | $0.11 | -$0.16 | -$0.23 | -$0.80 |
| EPS | $0.07 | -$0.12 | -$0.17 | -$0.53 |
| Diluted EPS | $0.07 | -$0.12 | -$0.17 | -$0.53 |
| Weighted Avg Shares Outstanding | $22.15M | $20.54M | $19.99M | $19.76M |
| Weighted Avg Shares Outstanding (Diluted) | $22.15M | $20.54M | $19.99M | $19.76M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan